nodes	percent_of_prediction	percent_of_DWPC	metapath
Enalapril—ABCB1—esophageal cancer	0.375	1	CbGaD
Enalapril—SLC22A7—Methotrexate—esophageal cancer	0.12	0.311	CbGbCtD
Enalapril—SLCO1A2—Methotrexate—esophageal cancer	0.0844	0.218	CbGbCtD
Enalapril—SLC22A8—Methotrexate—esophageal cancer	0.0735	0.19	CbGbCtD
Enalapril—SLC22A6—Methotrexate—esophageal cancer	0.0512	0.132	CbGbCtD
Enalapril—ABCB1—Cisplatin—esophageal cancer	0.0351	0.0907	CbGbCtD
Enalapril—ACE—thoracic aorta—esophageal cancer	0.0278	0.577	CbGeAlD
Enalapril—ABCB1—Methotrexate—esophageal cancer	0.0228	0.0589	CbGbCtD
Enalapril—ACE—neck—esophageal cancer	0.00245	0.0509	CbGeAlD
Enalapril—SLC15A1—epithelium—esophageal cancer	0.00232	0.0483	CbGeAlD
Enalapril—SLC22A7—digestive system—esophageal cancer	0.0022	0.0458	CbGeAlD
Enalapril—SLC15A1—digestive system—esophageal cancer	0.00177	0.0368	CbGeAlD
Enalapril—ACE—epithelium—esophageal cancer	0.00167	0.0347	CbGeAlD
Enalapril—ACE—smooth muscle tissue—esophageal cancer	0.00161	0.0334	CbGeAlD
Enalapril—SLCO1A2—digestive system—esophageal cancer	0.00133	0.0277	CbGeAlD
Enalapril—ACE—digestive system—esophageal cancer	0.00127	0.0264	CbGeAlD
Enalapril—SLCO1A2—lung—esophageal cancer	0.00111	0.0231	CbGeAlD
Enalapril—ACE—lung—esophageal cancer	0.00106	0.022	CbGeAlD
Enalapril—Captopril—ABCB1—esophageal cancer	0.000837	0.302	CrCbGaD
Enalapril—Herpes zoster—Methotrexate—esophageal cancer	0.000783	0.0054	CcSEcCtD
Enalapril—Melaena—Capecitabine—esophageal cancer	0.000774	0.00533	CcSEcCtD
Enalapril—Influenza like illness—Capecitabine—esophageal cancer	0.000769	0.0053	CcSEcCtD
Enalapril—Face oedema—Cisplatin—esophageal cancer	0.000753	0.00519	CcSEcCtD
Enalapril—Irritability—Cisplatin—esophageal cancer	0.000744	0.00513	CcSEcCtD
Enalapril—Dry eye—Capecitabine—esophageal cancer	0.000732	0.00504	CcSEcCtD
Enalapril—Blood creatinine increased—Cisplatin—esophageal cancer	0.000731	0.00504	CcSEcCtD
Enalapril—ACE—lymph node—esophageal cancer	0.000724	0.0151	CbGeAlD
Enalapril—Urine output increased—Capecitabine—esophageal cancer	0.000716	0.00494	CcSEcCtD
Enalapril—Orthostatic hypotension—Cisplatin—esophageal cancer	0.000712	0.00491	CcSEcCtD
Enalapril—Cramp muscle—Cisplatin—esophageal cancer	0.000702	0.00484	CcSEcCtD
Enalapril—Nasopharyngitis—Cisplatin—esophageal cancer	0.000697	0.00481	CcSEcCtD
Enalapril—Proteinuria—Methotrexate—esophageal cancer	0.000671	0.00463	CcSEcCtD
Enalapril—Protein urine present—Methotrexate—esophageal cancer	0.000662	0.00456	CcSEcCtD
Enalapril—Pancreatitis—Cisplatin—esophageal cancer	0.000661	0.00456	CcSEcCtD
Enalapril—Sweating increased—Cisplatin—esophageal cancer	0.000657	0.00453	CcSEcCtD
Enalapril—Photosensitivity—Capecitabine—esophageal cancer	0.000655	0.00451	CcSEcCtD
Enalapril—Polyuria—Capecitabine—esophageal cancer	0.000655	0.00451	CcSEcCtD
Enalapril—Swelling—Capecitabine—esophageal cancer	0.000652	0.00449	CcSEcCtD
Enalapril—Deafness—Capecitabine—esophageal cancer	0.000643	0.00443	CcSEcCtD
Enalapril—Pancytopenia—Cisplatin—esophageal cancer	0.00064	0.00441	CcSEcCtD
Enalapril—Glossitis—Methotrexate—esophageal cancer	0.00064	0.00441	CcSEcCtD
Enalapril—Oliguria—Methotrexate—esophageal cancer	0.00064	0.00441	CcSEcCtD
Enalapril—Hepatic failure—Capecitabine—esophageal cancer	0.00064	0.00441	CcSEcCtD
Enalapril—Haemolytic anaemia—Capecitabine—esophageal cancer	0.000637	0.00439	CcSEcCtD
Enalapril—CYP3A4—digestive system—esophageal cancer	0.000631	0.0131	CbGeAlD
Enalapril—Libido decreased—Capecitabine—esophageal cancer	0.00062	0.00427	CcSEcCtD
Enalapril—Hot flush—Capecitabine—esophageal cancer	0.000615	0.00424	CcSEcCtD
Enalapril—Dermatitis exfoliative—Capecitabine—esophageal cancer	0.000609	0.0042	CcSEcCtD
Enalapril—Menopausal symptoms—Capecitabine—esophageal cancer	0.000609	0.0042	CcSEcCtD
Enalapril—Atrial fibrillation—Capecitabine—esophageal cancer	0.000607	0.00418	CcSEcCtD
Enalapril—Vasculitis—Methotrexate—esophageal cancer	0.000604	0.00417	CcSEcCtD
Enalapril—Acute coronary syndrome—Cisplatin—esophageal cancer	0.000592	0.00409	CcSEcCtD
Enalapril—Arthritis—Capecitabine—esophageal cancer	0.000592	0.00408	CcSEcCtD
Enalapril—Renal failure—Cisplatin—esophageal cancer	0.000591	0.00407	CcSEcCtD
Enalapril—Pulmonary embolism—Methotrexate—esophageal cancer	0.00059	0.00407	CcSEcCtD
Enalapril—Neuropathy peripheral—Cisplatin—esophageal cancer	0.000589	0.00406	CcSEcCtD
Enalapril—Myocardial infarction—Cisplatin—esophageal cancer	0.000589	0.00406	CcSEcCtD
Enalapril—Cerebrovascular accident—Capecitabine—esophageal cancer	0.000587	0.00405	CcSEcCtD
Enalapril—ABCB1—epithelium—esophageal cancer	0.000587	0.0122	CbGeAlD
Enalapril—Stomatitis—Cisplatin—esophageal cancer	0.000586	0.00404	CcSEcCtD
Enalapril—Conjunctivitis—Cisplatin—esophageal cancer	0.000584	0.00403	CcSEcCtD
Enalapril—Hyponatraemia—Capecitabine—esophageal cancer	0.000577	0.00398	CcSEcCtD
Enalapril—Melaena—Methotrexate—esophageal cancer	0.000576	0.00397	CcSEcCtD
Enalapril—Pain in extremity—Capecitabine—esophageal cancer	0.000575	0.00396	CcSEcCtD
Enalapril—Disturbance in sexual arousal—Capecitabine—esophageal cancer	0.00057	0.00393	CcSEcCtD
Enalapril—Face oedema—Capecitabine—esophageal cancer	0.000555	0.00383	CcSEcCtD
Enalapril—Bradycardia—Cisplatin—esophageal cancer	0.000549	0.00379	CcSEcCtD
Enalapril—Irritability—Capecitabine—esophageal cancer	0.000549	0.00378	CcSEcCtD
Enalapril—Cardiac arrest—Capecitabine—esophageal cancer	0.000547	0.00377	CcSEcCtD
Enalapril—Ataxia—Capecitabine—esophageal cancer	0.000541	0.00373	CcSEcCtD
Enalapril—Blood creatinine increased—Capecitabine—esophageal cancer	0.000539	0.00371	CcSEcCtD
Enalapril—Urine output increased—Methotrexate—esophageal cancer	0.000533	0.00368	CcSEcCtD
Enalapril—Gynaecomastia—Methotrexate—esophageal cancer	0.000528	0.00364	CcSEcCtD
Enalapril—Perindopril—ABCB1—esophageal cancer	0.000527	0.19	CrCbGaD
Enalapril—Dry skin—Capecitabine—esophageal cancer	0.000527	0.00363	CcSEcCtD
Enalapril—Orthostatic hypotension—Capecitabine—esophageal cancer	0.000525	0.00362	CcSEcCtD
Enalapril—Pulmonary oedema—Methotrexate—esophageal cancer	0.000525	0.00362	CcSEcCtD
Enalapril—Visual impairment—Cisplatin—esophageal cancer	0.00052	0.00359	CcSEcCtD
Enalapril—ABCB1—trachea—esophageal cancer	0.000519	0.0108	CbGeAlD
Enalapril—Toxic epidermal necrolysis—Capecitabine—esophageal cancer	0.000518	0.00357	CcSEcCtD
Enalapril—Nasopharyngitis—Capecitabine—esophageal cancer	0.000514	0.00354	CcSEcCtD
Enalapril—Alanine aminotransferase increased—Capecitabine—esophageal cancer	0.000507	0.0035	CcSEcCtD
Enalapril—Tinnitus—Cisplatin—esophageal cancer	0.000503	0.00347	CcSEcCtD
Enalapril—Flushing—Cisplatin—esophageal cancer	0.000501	0.00345	CcSEcCtD
Enalapril—Dysphagia—Capecitabine—esophageal cancer	0.000497	0.00343	CcSEcCtD
Enalapril—Influenza—Capecitabine—esophageal cancer	0.000497	0.00343	CcSEcCtD
Enalapril—Asthma—Capecitabine—esophageal cancer	0.000497	0.00343	CcSEcCtD
Enalapril—Bronchospasm—Capecitabine—esophageal cancer	0.000489	0.00337	CcSEcCtD
Enalapril—Photosensitivity—Methotrexate—esophageal cancer	0.000487	0.00336	CcSEcCtD
Enalapril—Polyuria—Methotrexate—esophageal cancer	0.000487	0.00336	CcSEcCtD
Enalapril—Sweating increased—Capecitabine—esophageal cancer	0.000484	0.00334	CcSEcCtD
Enalapril—Angina pectoris—Capecitabine—esophageal cancer	0.000484	0.00334	CcSEcCtD
Enalapril—Arrhythmia—Cisplatin—esophageal cancer	0.000482	0.00332	CcSEcCtD
Enalapril—Nateglinide—PTGS1—esophageal cancer	0.000479	0.173	CrCbGaD
Enalapril—Bronchitis—Capecitabine—esophageal cancer	0.000478	0.0033	CcSEcCtD
Enalapril—Alopecia—Cisplatin—esophageal cancer	0.000477	0.00329	CcSEcCtD
Enalapril—Hepatic failure—Methotrexate—esophageal cancer	0.000476	0.00328	CcSEcCtD
Enalapril—Pancytopenia—Capecitabine—esophageal cancer	0.000472	0.00325	CcSEcCtD
Enalapril—Erythema—Cisplatin—esophageal cancer	0.00047	0.00324	CcSEcCtD
Enalapril—Dysuria—Capecitabine—esophageal cancer	0.000465	0.0032	CcSEcCtD
Enalapril—Neutropenia—Capecitabine—esophageal cancer	0.000465	0.0032	CcSEcCtD
Enalapril—Lisinopril—ABCB1—esophageal cancer	0.000464	0.168	CrCbGaD
Enalapril—Cilazapril—ABCB1—esophageal cancer	0.000464	0.168	CrCbGaD
Enalapril—Flatulence—Cisplatin—esophageal cancer	0.000463	0.00319	CcSEcCtD
Enalapril—Upper respiratory tract infection—Capecitabine—esophageal cancer	0.000462	0.00318	CcSEcCtD
Enalapril—Dermatitis exfoliative—Methotrexate—esophageal cancer	0.000454	0.00313	CcSEcCtD
Enalapril—Photosensitivity reaction—Capecitabine—esophageal cancer	0.000454	0.00313	CcSEcCtD
Enalapril—Visual disturbance—Methotrexate—esophageal cancer	0.000452	0.00311	CcSEcCtD
Enalapril—Muscle spasms—Cisplatin—esophageal cancer	0.000452	0.00311	CcSEcCtD
Enalapril—Hyperglycaemia—Capecitabine—esophageal cancer	0.000448	0.00309	CcSEcCtD
Enalapril—ABCB1—digestive system—esophageal cancer	0.000446	0.00928	CbGeAlD
Enalapril—Pneumonia—Capecitabine—esophageal cancer	0.000446	0.00307	CcSEcCtD
Enalapril—Vision blurred—Cisplatin—esophageal cancer	0.000443	0.00305	CcSEcCtD
Enalapril—Anaphylactoid reaction—Methotrexate—esophageal cancer	0.000442	0.00305	CcSEcCtD
Enalapril—Depression—Capecitabine—esophageal cancer	0.000442	0.00305	CcSEcCtD
Enalapril—Tremor—Cisplatin—esophageal cancer	0.00044	0.00303	CcSEcCtD
Enalapril—Stevens-Johnson syndrome—Capecitabine—esophageal cancer	0.000439	0.00303	CcSEcCtD
Enalapril—Acute coronary syndrome—Capecitabine—esophageal cancer	0.000437	0.00301	CcSEcCtD
Enalapril—Cerebrovascular accident—Methotrexate—esophageal cancer	0.000437	0.00301	CcSEcCtD
Enalapril—Renal failure—Capecitabine—esophageal cancer	0.000436	0.003	CcSEcCtD
Enalapril—Neuropathy peripheral—Capecitabine—esophageal cancer	0.000434	0.00299	CcSEcCtD
Enalapril—Myocardial infarction—Capecitabine—esophageal cancer	0.000434	0.00299	CcSEcCtD
Enalapril—Anaemia—Cisplatin—esophageal cancer	0.000434	0.00299	CcSEcCtD
Enalapril—Stomatitis—Capecitabine—esophageal cancer	0.000432	0.00298	CcSEcCtD
Enalapril—Jaundice—Capecitabine—esophageal cancer	0.000432	0.00298	CcSEcCtD
Enalapril—Urinary tract infection—Capecitabine—esophageal cancer	0.000431	0.00297	CcSEcCtD
Enalapril—Conjunctivitis—Capecitabine—esophageal cancer	0.000431	0.00297	CcSEcCtD
Enalapril—Leukopenia—Cisplatin—esophageal cancer	0.00042	0.0029	CcSEcCtD
Enalapril—Epistaxis—Capecitabine—esophageal cancer	0.000418	0.00288	CcSEcCtD
Enalapril—Agranulocytosis—Capecitabine—esophageal cancer	0.000413	0.00285	CcSEcCtD
Enalapril—Irritability—Methotrexate—esophageal cancer	0.000408	0.00282	CcSEcCtD
Enalapril—Bradycardia—Capecitabine—esophageal cancer	0.000405	0.00279	CcSEcCtD
Enalapril—Ataxia—Methotrexate—esophageal cancer	0.000402	0.00277	CcSEcCtD
Enalapril—Myalgia—Cisplatin—esophageal cancer	0.0004	0.00276	CcSEcCtD
Enalapril—Hepatitis—Capecitabine—esophageal cancer	0.000398	0.00274	CcSEcCtD
Enalapril—Discomfort—Cisplatin—esophageal cancer	0.000395	0.00272	CcSEcCtD
Enalapril—Pharyngitis—Capecitabine—esophageal cancer	0.000395	0.00272	CcSEcCtD
Enalapril—Toxic epidermal necrolysis—Methotrexate—esophageal cancer	0.000385	0.00266	CcSEcCtD
Enalapril—Anaphylactic shock—Cisplatin—esophageal cancer	0.000383	0.00264	CcSEcCtD
Enalapril—Oedema—Cisplatin—esophageal cancer	0.000383	0.00264	CcSEcCtD
Enalapril—Visual impairment—Capecitabine—esophageal cancer	0.000383	0.00264	CcSEcCtD
Enalapril—Erythema multiforme—Capecitabine—esophageal cancer	0.000376	0.00259	CcSEcCtD
Enalapril—Thrombocytopenia—Cisplatin—esophageal cancer	0.000375	0.00259	CcSEcCtD
Enalapril—Tachycardia—Cisplatin—esophageal cancer	0.000374	0.00258	CcSEcCtD
Enalapril—ABCB1—lung—esophageal cancer	0.000373	0.00775	CbGeAlD
Enalapril—Tinnitus—Capecitabine—esophageal cancer	0.000371	0.00256	CcSEcCtD
Enalapril—Hyperhidrosis—Cisplatin—esophageal cancer	0.000371	0.00256	CcSEcCtD
Enalapril—Asthma—Methotrexate—esophageal cancer	0.00037	0.00255	CcSEcCtD
Enalapril—Flushing—Capecitabine—esophageal cancer	0.000369	0.00255	CcSEcCtD
Enalapril—Eosinophilia—Methotrexate—esophageal cancer	0.000366	0.00253	CcSEcCtD
Enalapril—Anorexia—Cisplatin—esophageal cancer	0.000365	0.00252	CcSEcCtD
Enalapril—Pancreatitis—Methotrexate—esophageal cancer	0.000363	0.0025	CcSEcCtD
Enalapril—Hypotension—Cisplatin—esophageal cancer	0.000358	0.00247	CcSEcCtD
Enalapril—Arrhythmia—Capecitabine—esophageal cancer	0.000355	0.00245	CcSEcCtD
Enalapril—Alopecia—Capecitabine—esophageal cancer	0.000351	0.00242	CcSEcCtD
Enalapril—Pancytopenia—Methotrexate—esophageal cancer	0.000351	0.00242	CcSEcCtD
Enalapril—Musculoskeletal discomfort—Cisplatin—esophageal cancer	0.000349	0.00241	CcSEcCtD
Enalapril—Erythema—Capecitabine—esophageal cancer	0.000346	0.00239	CcSEcCtD
Enalapril—Neutropenia—Methotrexate—esophageal cancer	0.000346	0.00239	CcSEcCtD
Enalapril—Dysuria—Methotrexate—esophageal cancer	0.000346	0.00239	CcSEcCtD
Enalapril—Paraesthesia—Cisplatin—esophageal cancer	0.000344	0.00237	CcSEcCtD
Enalapril—Upper respiratory tract infection—Methotrexate—esophageal cancer	0.000344	0.00237	CcSEcCtD
Enalapril—Dyspnoea—Cisplatin—esophageal cancer	0.000342	0.00236	CcSEcCtD
Enalapril—Flatulence—Capecitabine—esophageal cancer	0.000341	0.00235	CcSEcCtD
Enalapril—Erectile dysfunction—Methotrexate—esophageal cancer	0.000341	0.00235	CcSEcCtD
Enalapril—Dysgeusia—Capecitabine—esophageal cancer	0.000339	0.00234	CcSEcCtD
Enalapril—Photosensitivity reaction—Methotrexate—esophageal cancer	0.000338	0.00233	CcSEcCtD
Enalapril—Back pain—Capecitabine—esophageal cancer	0.000335	0.00231	CcSEcCtD
Enalapril—Decreased appetite—Cisplatin—esophageal cancer	0.000333	0.0023	CcSEcCtD
Enalapril—Muscle spasms—Capecitabine—esophageal cancer	0.000333	0.0023	CcSEcCtD
Enalapril—Pneumonia—Methotrexate—esophageal cancer	0.000332	0.00229	CcSEcCtD
Enalapril—Depression—Methotrexate—esophageal cancer	0.000329	0.00227	CcSEcCtD
Enalapril—Stevens-Johnson syndrome—Methotrexate—esophageal cancer	0.000327	0.00225	CcSEcCtD
Enalapril—Vision blurred—Capecitabine—esophageal cancer	0.000326	0.00225	CcSEcCtD
Enalapril—Tremor—Capecitabine—esophageal cancer	0.000324	0.00224	CcSEcCtD
Enalapril—Renal failure—Methotrexate—esophageal cancer	0.000324	0.00224	CcSEcCtD
Enalapril—Stomatitis—Methotrexate—esophageal cancer	0.000321	0.00222	CcSEcCtD
Enalapril—Conjunctivitis—Methotrexate—esophageal cancer	0.000321	0.00221	CcSEcCtD
Enalapril—Anaemia—Capecitabine—esophageal cancer	0.00032	0.00221	CcSEcCtD
Enalapril—Feeling abnormal—Cisplatin—esophageal cancer	0.000316	0.00218	CcSEcCtD
Enalapril—Epistaxis—Methotrexate—esophageal cancer	0.000311	0.00215	CcSEcCtD
Enalapril—Vertigo—Capecitabine—esophageal cancer	0.000311	0.00214	CcSEcCtD
Enalapril—Syncope—Capecitabine—esophageal cancer	0.00031	0.00214	CcSEcCtD
Enalapril—Leukopenia—Capecitabine—esophageal cancer	0.00031	0.00214	CcSEcCtD
Enalapril—Agranulocytosis—Methotrexate—esophageal cancer	0.000308	0.00212	CcSEcCtD
Enalapril—Palpitations—Capecitabine—esophageal cancer	0.000306	0.00211	CcSEcCtD
Enalapril—Loss of consciousness—Capecitabine—esophageal cancer	0.000304	0.0021	CcSEcCtD
Enalapril—Body temperature increased—Cisplatin—esophageal cancer	0.000303	0.00209	CcSEcCtD
Enalapril—Cough—Capecitabine—esophageal cancer	0.000302	0.00208	CcSEcCtD
Enalapril—Hepatitis—Methotrexate—esophageal cancer	0.000296	0.00204	CcSEcCtD
Enalapril—Arthralgia—Capecitabine—esophageal cancer	0.000295	0.00203	CcSEcCtD
Enalapril—Myalgia—Capecitabine—esophageal cancer	0.000295	0.00203	CcSEcCtD
Enalapril—Chest pain—Capecitabine—esophageal cancer	0.000295	0.00203	CcSEcCtD
Enalapril—Pharyngitis—Methotrexate—esophageal cancer	0.000294	0.00203	CcSEcCtD
Enalapril—Discomfort—Capecitabine—esophageal cancer	0.000291	0.00201	CcSEcCtD
Enalapril—Dry mouth—Capecitabine—esophageal cancer	0.000288	0.00199	CcSEcCtD
Enalapril—Visual impairment—Methotrexate—esophageal cancer	0.000285	0.00197	CcSEcCtD
Enalapril—Confusional state—Capecitabine—esophageal cancer	0.000285	0.00196	CcSEcCtD
Enalapril—Oedema—Capecitabine—esophageal cancer	0.000283	0.00195	CcSEcCtD
Enalapril—Hypersensitivity—Cisplatin—esophageal cancer	0.000282	0.00195	CcSEcCtD
Enalapril—Erythema multiforme—Methotrexate—esophageal cancer	0.00028	0.00193	CcSEcCtD
Enalapril—Shock—Capecitabine—esophageal cancer	0.000278	0.00192	CcSEcCtD
Enalapril—Thrombocytopenia—Capecitabine—esophageal cancer	0.000277	0.00191	CcSEcCtD
Enalapril—Tinnitus—Methotrexate—esophageal cancer	0.000276	0.0019	CcSEcCtD
Enalapril—Tachycardia—Capecitabine—esophageal cancer	0.000276	0.0019	CcSEcCtD
Enalapril—Asthenia—Cisplatin—esophageal cancer	0.000275	0.0019	CcSEcCtD
Enalapril—Hyperhidrosis—Capecitabine—esophageal cancer	0.000273	0.00188	CcSEcCtD
Enalapril—Anorexia—Capecitabine—esophageal cancer	0.000269	0.00186	CcSEcCtD
Enalapril—Hypotension—Capecitabine—esophageal cancer	0.000264	0.00182	CcSEcCtD
Enalapril—Diarrhoea—Cisplatin—esophageal cancer	0.000262	0.00181	CcSEcCtD
Enalapril—Alopecia—Methotrexate—esophageal cancer	0.000262	0.0018	CcSEcCtD
Enalapril—Erythema—Methotrexate—esophageal cancer	0.000258	0.00178	CcSEcCtD
Enalapril—Musculoskeletal discomfort—Capecitabine—esophageal cancer	0.000257	0.00178	CcSEcCtD
Enalapril—Insomnia—Capecitabine—esophageal cancer	0.000256	0.00176	CcSEcCtD
Enalapril—ABCB1—lymph node—esophageal cancer	0.000255	0.0053	CbGeAlD
Enalapril—Paraesthesia—Capecitabine—esophageal cancer	0.000254	0.00175	CcSEcCtD
Enalapril—Dysgeusia—Methotrexate—esophageal cancer	0.000252	0.00174	CcSEcCtD
Enalapril—Dyspnoea—Capecitabine—esophageal cancer	0.000252	0.00174	CcSEcCtD
Enalapril—Back pain—Methotrexate—esophageal cancer	0.000249	0.00172	CcSEcCtD
Enalapril—Dyspepsia—Capecitabine—esophageal cancer	0.000249	0.00172	CcSEcCtD
Enalapril—Decreased appetite—Capecitabine—esophageal cancer	0.000246	0.00169	CcSEcCtD
Enalapril—Vomiting—Cisplatin—esophageal cancer	0.000244	0.00168	CcSEcCtD
Enalapril—Fatigue—Capecitabine—esophageal cancer	0.000244	0.00168	CcSEcCtD
Enalapril—Vision blurred—Methotrexate—esophageal cancer	0.000243	0.00167	CcSEcCtD
Enalapril—Rash—Cisplatin—esophageal cancer	0.000242	0.00167	CcSEcCtD
Enalapril—Constipation—Capecitabine—esophageal cancer	0.000242	0.00167	CcSEcCtD
Enalapril—Dermatitis—Cisplatin—esophageal cancer	0.000241	0.00167	CcSEcCtD
Enalapril—Anaemia—Methotrexate—esophageal cancer	0.000238	0.00164	CcSEcCtD
Enalapril—Feeling abnormal—Capecitabine—esophageal cancer	0.000233	0.00161	CcSEcCtD
Enalapril—Vertigo—Methotrexate—esophageal cancer	0.000232	0.0016	CcSEcCtD
Enalapril—Gastrointestinal pain—Capecitabine—esophageal cancer	0.000231	0.00159	CcSEcCtD
Enalapril—Leukopenia—Methotrexate—esophageal cancer	0.000231	0.00159	CcSEcCtD
Enalapril—Nausea—Cisplatin—esophageal cancer	0.000228	0.00157	CcSEcCtD
Enalapril—Cough—Methotrexate—esophageal cancer	0.000225	0.00155	CcSEcCtD
Enalapril—Urticaria—Capecitabine—esophageal cancer	0.000224	0.00155	CcSEcCtD
Enalapril—Abdominal pain—Capecitabine—esophageal cancer	0.000223	0.00154	CcSEcCtD
Enalapril—Body temperature increased—Capecitabine—esophageal cancer	0.000223	0.00154	CcSEcCtD
Enalapril—Arthralgia—Methotrexate—esophageal cancer	0.000219	0.00151	CcSEcCtD
Enalapril—Chest pain—Methotrexate—esophageal cancer	0.000219	0.00151	CcSEcCtD
Enalapril—Myalgia—Methotrexate—esophageal cancer	0.000219	0.00151	CcSEcCtD
Enalapril—Discomfort—Methotrexate—esophageal cancer	0.000217	0.00149	CcSEcCtD
Enalapril—Confusional state—Methotrexate—esophageal cancer	0.000212	0.00146	CcSEcCtD
Enalapril—Anaphylactic shock—Methotrexate—esophageal cancer	0.00021	0.00145	CcSEcCtD
Enalapril—Hypersensitivity—Capecitabine—esophageal cancer	0.000208	0.00144	CcSEcCtD
Enalapril—Thrombocytopenia—Methotrexate—esophageal cancer	0.000206	0.00142	CcSEcCtD
Enalapril—SLCO1A2—SLC-mediated transmembrane transport—SLC30A7—esophageal cancer	0.000206	0.00492	CbGpPWpGaD
Enalapril—Hyperhidrosis—Methotrexate—esophageal cancer	0.000203	0.0014	CcSEcCtD
Enalapril—Asthenia—Capecitabine—esophageal cancer	0.000203	0.0014	CcSEcCtD
Enalapril—Anorexia—Methotrexate—esophageal cancer	0.000201	0.00138	CcSEcCtD
Enalapril—Pruritus—Capecitabine—esophageal cancer	0.0002	0.00138	CcSEcCtD
Enalapril—CYP3A4—Tamoxifen metabolism—CYP1B1—esophageal cancer	0.000198	0.00475	CbGpPWpGaD
Enalapril—Hypotension—Methotrexate—esophageal cancer	0.000197	0.00136	CcSEcCtD
Enalapril—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—esophageal cancer	0.000193	0.00463	CbGpPWpGaD
Enalapril—SLC22A6—SLC-mediated transmembrane transport—SLC30A7—esophageal cancer	0.000193	0.00463	CbGpPWpGaD
Enalapril—Diarrhoea—Capecitabine—esophageal cancer	0.000193	0.00133	CcSEcCtD
Enalapril—Musculoskeletal discomfort—Methotrexate—esophageal cancer	0.000192	0.00132	CcSEcCtD
Enalapril—Insomnia—Methotrexate—esophageal cancer	0.00019	0.00131	CcSEcCtD
Enalapril—Paraesthesia—Methotrexate—esophageal cancer	0.000189	0.0013	CcSEcCtD
Enalapril—SLC22A7—Fluoropyrimidine Activity—TP53—esophageal cancer	0.000188	0.00451	CbGpPWpGaD
Enalapril—Dyspnoea—Methotrexate—esophageal cancer	0.000188	0.00129	CcSEcCtD
Enalapril—ACE—Metabolism of proteins—ST6GAL1—esophageal cancer	0.000187	0.00448	CbGpPWpGaD
Enalapril—Somnolence—Methotrexate—esophageal cancer	0.000187	0.00129	CcSEcCtD
Enalapril—Dizziness—Capecitabine—esophageal cancer	0.000187	0.00129	CcSEcCtD
Enalapril—Dyspepsia—Methotrexate—esophageal cancer	0.000185	0.00128	CcSEcCtD
Enalapril—Decreased appetite—Methotrexate—esophageal cancer	0.000183	0.00126	CcSEcCtD
Enalapril—Fatigue—Methotrexate—esophageal cancer	0.000181	0.00125	CcSEcCtD
Enalapril—Vomiting—Capecitabine—esophageal cancer	0.00018	0.00124	CcSEcCtD
Enalapril—Rash—Capecitabine—esophageal cancer	0.000178	0.00123	CcSEcCtD
Enalapril—Dermatitis—Capecitabine—esophageal cancer	0.000178	0.00123	CcSEcCtD
Enalapril—Headache—Capecitabine—esophageal cancer	0.000177	0.00122	CcSEcCtD
Enalapril—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2A6—esophageal cancer	0.000176	0.00421	CbGpPWpGaD
Enalapril—Feeling abnormal—Methotrexate—esophageal cancer	0.000173	0.0012	CcSEcCtD
Enalapril—Gastrointestinal pain—Methotrexate—esophageal cancer	0.000172	0.00119	CcSEcCtD
Enalapril—SLC22A7—Transmembrane transport of small molecules—SLC10A2—esophageal cancer	0.000172	0.00411	CbGpPWpGaD
Enalapril—Nausea—Capecitabine—esophageal cancer	0.000168	0.00116	CcSEcCtD
Enalapril—Urticaria—Methotrexate—esophageal cancer	0.000167	0.00115	CcSEcCtD
Enalapril—Abdominal pain—Methotrexate—esophageal cancer	0.000166	0.00115	CcSEcCtD
Enalapril—Body temperature increased—Methotrexate—esophageal cancer	0.000166	0.00115	CcSEcCtD
Enalapril—SLC15A1—Transmembrane transport of small molecules—SLC10A2—esophageal cancer	0.000162	0.00389	CbGpPWpGaD
Enalapril—SLC22A7—Transmembrane transport of small molecules—ATP1B2—esophageal cancer	0.000162	0.00387	CbGpPWpGaD
Enalapril—Hypersensitivity—Methotrexate—esophageal cancer	0.000155	0.00107	CcSEcCtD
Enalapril—SLC22A7—Transmembrane transport of small molecules—SLC39A6—esophageal cancer	0.000153	0.00367	CbGpPWpGaD
Enalapril—SLC15A1—Transmembrane transport of small molecules—ATP1B2—esophageal cancer	0.000153	0.00365	CbGpPWpGaD
Enalapril—ABCB1—HIF-1-alpha transcription factor network—ENO1—esophageal cancer	0.000151	0.00363	CbGpPWpGaD
Enalapril—Asthenia—Methotrexate—esophageal cancer	0.000151	0.00104	CcSEcCtD
Enalapril—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP26A1—esophageal cancer	0.000149	0.00357	CbGpPWpGaD
Enalapril—Pruritus—Methotrexate—esophageal cancer	0.000149	0.00103	CcSEcCtD
Enalapril—CYP3A4—Phase 1 - Functionalization of compounds—ADH7—esophageal cancer	0.000148	0.00355	CbGpPWpGaD
Enalapril—CYP3A4—Oxidation by Cytochrome P450—CYP26A1—esophageal cancer	0.000147	0.00352	CbGpPWpGaD
Enalapril—SLC22A7—Transmembrane transport of small molecules—AQP3—esophageal cancer	0.000146	0.0035	CbGpPWpGaD
Enalapril—SLC15A1—Transmembrane transport of small molecules—SLC39A6—esophageal cancer	0.000145	0.00346	CbGpPWpGaD
Enalapril—SLC22A8—Transmembrane transport of small molecules—SLC10A2—esophageal cancer	0.000144	0.00346	CbGpPWpGaD
Enalapril—Diarrhoea—Methotrexate—esophageal cancer	0.000144	0.000992	CcSEcCtD
Enalapril—SLC22A7—Transmembrane transport of small molecules—ATP4A—esophageal cancer	0.00014	0.00335	CbGpPWpGaD
Enalapril—SLC22A7—Transmembrane transport of small molecules—SLC30A7—esophageal cancer	0.00014	0.00335	CbGpPWpGaD
Enalapril—CYP3A4—Tryptophan metabolism—ALDH2—esophageal cancer	0.00014	0.00335	CbGpPWpGaD
Enalapril—Dizziness—Methotrexate—esophageal cancer	0.000139	0.000959	CcSEcCtD
Enalapril—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—ABL1—esophageal cancer	0.000139	0.00333	CbGpPWpGaD
Enalapril—SLC15A1—Transmembrane transport of small molecules—AQP3—esophageal cancer	0.000138	0.00331	CbGpPWpGaD
Enalapril—SLC22A8—Transmembrane transport of small molecules—ATP1B2—esophageal cancer	0.000136	0.00325	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism of lipids and lipoproteins—SLC10A2—esophageal cancer	0.000135	0.00323	CbGpPWpGaD
Enalapril—Vomiting—Methotrexate—esophageal cancer	0.000134	0.000922	CcSEcCtD
Enalapril—Rash—Methotrexate—esophageal cancer	0.000133	0.000915	CcSEcCtD
Enalapril—Dermatitis—Methotrexate—esophageal cancer	0.000133	0.000914	CcSEcCtD
Enalapril—SLC15A1—Transmembrane transport of small molecules—ATP4A—esophageal cancer	0.000132	0.00317	CbGpPWpGaD
Enalapril—SLC15A1—Transmembrane transport of small molecules—SLC30A7—esophageal cancer	0.000132	0.00317	CbGpPWpGaD
Enalapril—Headache—Methotrexate—esophageal cancer	0.000132	0.000909	CcSEcCtD
Enalapril—CYP3A4—Phase 1 - Functionalization of compounds—ADH1B—esophageal cancer	0.00013	0.00311	CbGpPWpGaD
Enalapril—ACE—Metabolism of proteins—ACTB—esophageal cancer	0.000129	0.00308	CbGpPWpGaD
Enalapril—SLC22A8—Transmembrane transport of small molecules—SLC39A6—esophageal cancer	0.000129	0.00308	CbGpPWpGaD
Enalapril—SLCO1A2—Transmembrane transport of small molecules—SLC10A2—esophageal cancer	0.000128	0.00307	CbGpPWpGaD
Enalapril—Nausea—Methotrexate—esophageal cancer	0.000125	0.000862	CcSEcCtD
Enalapril—SLC22A8—Transmembrane transport of small molecules—AQP3—esophageal cancer	0.000123	0.00294	CbGpPWpGaD
Enalapril—CYP3A4—Phase 1 - Functionalization of compounds—CYP26A1—esophageal cancer	0.000121	0.00289	CbGpPWpGaD
Enalapril—SLCO1A2—Transmembrane transport of small molecules—ATP1B2—esophageal cancer	0.000121	0.00289	CbGpPWpGaD
Enalapril—SLC22A6—Transmembrane transport of small molecules—SLC10A2—esophageal cancer	0.000121	0.00289	CbGpPWpGaD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—FKBP1A—esophageal cancer	0.00012	0.00288	CbGpPWpGaD
Enalapril—SLC22A8—Transmembrane transport of small molecules—SLC30A7—esophageal cancer	0.000118	0.00282	CbGpPWpGaD
Enalapril—SLC22A8—Transmembrane transport of small molecules—ATP4A—esophageal cancer	0.000118	0.00282	CbGpPWpGaD
Enalapril—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—esophageal cancer	0.000117	0.00279	CbGpPWpGaD
Enalapril—ACE—Metabolism of proteins—HSPA5—esophageal cancer	0.000116	0.00279	CbGpPWpGaD
Enalapril—SLCO1A2—Transmembrane transport of small molecules—SLC39A6—esophageal cancer	0.000114	0.00274	CbGpPWpGaD
Enalapril—SLC22A6—Transmembrane transport of small molecules—ATP1B2—esophageal cancer	0.000113	0.00271	CbGpPWpGaD
Enalapril—ACE—Metabolism of proteins—CALR—esophageal cancer	0.000113	0.0027	CbGpPWpGaD
Enalapril—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—esophageal cancer	0.000111	0.00266	CbGpPWpGaD
Enalapril—ACE—Metabolism of proteins—GHRL—esophageal cancer	0.000111	0.00265	CbGpPWpGaD
Enalapril—ABCB1—HIF-1-alpha transcription factor network—HMOX1—esophageal cancer	0.000111	0.00265	CbGpPWpGaD
Enalapril—ACE—Metabolism of proteins—FBXW7—esophageal cancer	0.000109	0.00261	CbGpPWpGaD
Enalapril—SLCO1A2—Transmembrane transport of small molecules—AQP3—esophageal cancer	0.000109	0.00261	CbGpPWpGaD
Enalapril—SLC22A6—Transmembrane transport of small molecules—SLC39A6—esophageal cancer	0.000107	0.00257	CbGpPWpGaD
Enalapril—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A6—esophageal cancer	0.000106	0.00254	CbGpPWpGaD
Enalapril—SLC22A7—Transmembrane transport of small molecules—ABCC2—esophageal cancer	0.000106	0.00254	CbGpPWpGaD
Enalapril—ABCB1—HIF-1-alpha transcription factor network—SMAD4—esophageal cancer	0.000106	0.00254	CbGpPWpGaD
Enalapril—CYP3A4—Tryptophan metabolism—CYP1B1—esophageal cancer	0.000106	0.00254	CbGpPWpGaD
Enalapril—CYP3A4—Oxidation by Cytochrome P450—CYP2A6—esophageal cancer	0.000105	0.00251	CbGpPWpGaD
Enalapril—SLCO1A2—Transmembrane transport of small molecules—ATP4A—esophageal cancer	0.000105	0.0025	CbGpPWpGaD
Enalapril—SLCO1A2—Transmembrane transport of small molecules—SLC30A7—esophageal cancer	0.000105	0.0025	CbGpPWpGaD
Enalapril—SLC22A6—Transmembrane transport of small molecules—AQP3—esophageal cancer	0.000102	0.00245	CbGpPWpGaD
Enalapril—SLC15A1—Transmembrane transport of small molecules—ABCC2—esophageal cancer	0.0001	0.0024	CbGpPWpGaD
Enalapril—CYP3A4—Tryptophan metabolism—CYP19A1—esophageal cancer	9.96e-05	0.00238	CbGpPWpGaD
Enalapril—SLC22A6—Transmembrane transport of small molecules—SLC30A7—esophageal cancer	9.83e-05	0.00235	CbGpPWpGaD
Enalapril—SLC22A6—Transmembrane transport of small molecules—ATP4A—esophageal cancer	9.83e-05	0.00235	CbGpPWpGaD
Enalapril—SLC22A7—Transmembrane transport of small molecules—GNG7—esophageal cancer	9.63e-05	0.00231	CbGpPWpGaD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—BBC3—esophageal cancer	9.34e-05	0.00224	CbGpPWpGaD
Enalapril—CYP3A4—Phase 1 - Functionalization of compounds—ALDH2—esophageal cancer	9.16e-05	0.00219	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism of lipids and lipoproteins—ALOX15—esophageal cancer	9.11e-05	0.00218	CbGpPWpGaD
Enalapril—SLC15A1—Transmembrane transport of small molecules—GNG7—esophageal cancer	9.1e-05	0.00218	CbGpPWpGaD
Enalapril—SLC22A8—Transmembrane transport of small molecules—ABCC2—esophageal cancer	8.92e-05	0.00214	CbGpPWpGaD
Enalapril—ABCB1—HIF-1-alpha transcription factor network—HIF1A—esophageal cancer	8.68e-05	0.00208	CbGpPWpGaD
Enalapril—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A6—esophageal cancer	8.61e-05	0.00206	CbGpPWpGaD
Enalapril—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—esophageal cancer	8.56e-05	0.00205	CbGpPWpGaD
Enalapril—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—esophageal cancer	8.45e-05	0.00202	CbGpPWpGaD
Enalapril—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—esophageal cancer	8.17e-05	0.00195	CbGpPWpGaD
Enalapril—SLC22A8—Transmembrane transport of small molecules—GNG7—esophageal cancer	8.1e-05	0.00194	CbGpPWpGaD
Enalapril—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—esophageal cancer	8.05e-05	0.00193	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism of lipids and lipoproteins—CRABP1—esophageal cancer	7.95e-05	0.0019	CbGpPWpGaD
Enalapril—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—esophageal cancer	7.95e-05	0.0019	CbGpPWpGaD
Enalapril—SLCO1A2—Transmembrane transport of small molecules—ABCC2—esophageal cancer	7.92e-05	0.0019	CbGpPWpGaD
Enalapril—ABCB1—HIF-1-alpha transcription factor network—NOS2—esophageal cancer	7.89e-05	0.00189	CbGpPWpGaD
Enalapril—CYP3A4—Biological oxidations—ADH7—esophageal cancer	7.88e-05	0.00189	CbGpPWpGaD
Enalapril—SLC22A6—Transmembrane transport of small molecules—ABCC2—esophageal cancer	7.45e-05	0.00178	CbGpPWpGaD
Enalapril—SLCO1A2—Transmembrane transport of small molecules—GNG7—esophageal cancer	7.19e-05	0.00172	CbGpPWpGaD
Enalapril—ABCB1—HIF-1-alpha transcription factor network—CREBBP—esophageal cancer	7.09e-05	0.0017	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—BLVRB—esophageal cancer	7.06e-05	0.00169	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—SLC52A3—esophageal cancer	7.06e-05	0.00169	CbGpPWpGaD
Enalapril—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—esophageal cancer	6.94e-05	0.00166	CbGpPWpGaD
Enalapril—CYP3A4—Biological oxidations—ADH1B—esophageal cancer	6.91e-05	0.00165	CbGpPWpGaD
Enalapril—SLC22A6—Transmembrane transport of small molecules—GNG7—esophageal cancer	6.76e-05	0.00162	CbGpPWpGaD
Enalapril—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—esophageal cancer	6.53e-05	0.00156	CbGpPWpGaD
Enalapril—CYP3A4—Biological oxidations—CYP26A1—esophageal cancer	6.42e-05	0.00154	CbGpPWpGaD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—ANXA1—esophageal cancer	6.35e-05	0.00152	CbGpPWpGaD
Enalapril—CYP3A4—Metapathway biotransformation—CYP26A1—esophageal cancer	6.33e-05	0.00152	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	6.32e-05	0.00151	CbGpPWpGaD
Enalapril—ABCB1—Allograft Rejection—CASP8—esophageal cancer	6.17e-05	0.00148	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—SLC10A2—esophageal cancer	6.01e-05	0.00144	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—CA1—esophageal cancer	6.01e-05	0.00144	CbGpPWpGaD
Enalapril—CYP3A4—Biological oxidations—GSTO1—esophageal cancer	5.97e-05	0.00143	CbGpPWpGaD
Enalapril—CYP3A4—Metapathway biotransformation—GSTO1—esophageal cancer	5.89e-05	0.00141	CbGpPWpGaD
Enalapril—SLC22A7—Transmembrane transport of small molecules—HMOX1—esophageal cancer	5.87e-05	0.00141	CbGpPWpGaD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—BUB1B—esophageal cancer	5.81e-05	0.00139	CbGpPWpGaD
Enalapril—SLC22A7—Transmembrane transport of small molecules—ABCB1—esophageal cancer	5.63e-05	0.00135	CbGpPWpGaD
Enalapril—SLC15A1—Transmembrane transport of small molecules—HMOX1—esophageal cancer	5.55e-05	0.00133	CbGpPWpGaD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—CHEK2—esophageal cancer	5.52e-05	0.00132	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—CA2—esophageal cancer	5.49e-05	0.00132	CbGpPWpGaD
Enalapril—ABCB1—Transmembrane transport of small molecules—SLC10A2—esophageal cancer	5.49e-05	0.00131	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	5.37e-05	0.00129	CbGpPWpGaD
Enalapril—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—esophageal cancer	5.34e-05	0.00128	CbGpPWpGaD
Enalapril—SLC15A1—Transmembrane transport of small molecules—ABCB1—esophageal cancer	5.32e-05	0.00127	CbGpPWpGaD
Enalapril—ABCB1—Transmembrane transport of small molecules—ATP1B2—esophageal cancer	5.16e-05	0.00124	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—PLCE1—esophageal cancer	5.11e-05	0.00122	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—ADH7—esophageal cancer	5.11e-05	0.00122	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	5.05e-05	0.00121	CbGpPWpGaD
Enalapril—SLC22A8—Transmembrane transport of small molecules—HMOX1—esophageal cancer	4.93e-05	0.00118	CbGpPWpGaD
Enalapril—ABCB1—Transmembrane transport of small molecules—SLC39A6—esophageal cancer	4.89e-05	0.00117	CbGpPWpGaD
Enalapril—CYP3A4—Biological oxidations—ALDH2—esophageal cancer	4.87e-05	0.00116	CbGpPWpGaD
Enalapril—ABCB1—HIF-1-alpha transcription factor network—EP300—esophageal cancer	4.83e-05	0.00116	CbGpPWpGaD
Enalapril—SLC22A8—Transmembrane transport of small molecules—ABCB1—esophageal cancer	4.74e-05	0.00113	CbGpPWpGaD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—ABL1—esophageal cancer	4.68e-05	0.00112	CbGpPWpGaD
Enalapril—ABCB1—Transmembrane transport of small molecules—AQP3—esophageal cancer	4.67e-05	0.00112	CbGpPWpGaD
Enalapril—CYP3A4—Biological oxidations—GSTT1—esophageal cancer	4.63e-05	0.00111	CbGpPWpGaD
Enalapril—CYP3A4—Biological oxidations—CYP2A6—esophageal cancer	4.58e-05	0.0011	CbGpPWpGaD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—SMAD4—esophageal cancer	4.53e-05	0.00109	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—ADH1B—esophageal cancer	4.48e-05	0.00107	CbGpPWpGaD
Enalapril—ABCB1—Transmembrane transport of small molecules—ATP4A—esophageal cancer	4.48e-05	0.00107	CbGpPWpGaD
Enalapril—ABCB1—Transmembrane transport of small molecules—SLC30A7—esophageal cancer	4.48e-05	0.00107	CbGpPWpGaD
Enalapril—SLCO1A2—Transmembrane transport of small molecules—HMOX1—esophageal cancer	4.38e-05	0.00105	CbGpPWpGaD
Enalapril—CYP3A4—Biological oxidations—PTGS1—esophageal cancer	4.34e-05	0.00104	CbGpPWpGaD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—BAX—esophageal cancer	4.29e-05	0.00103	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—TYMP—esophageal cancer	4.28e-05	0.00102	CbGpPWpGaD
Enalapril—SLCO1A2—Transmembrane transport of small molecules—ABCB1—esophageal cancer	4.2e-05	0.00101	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—CYP26A1—esophageal cancer	4.16e-05	0.000997	CbGpPWpGaD
Enalapril—SLC22A6—Transmembrane transport of small molecules—HMOX1—esophageal cancer	4.12e-05	0.000986	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—ALOX15—esophageal cancer	4.06e-05	0.000971	CbGpPWpGaD
Enalapril—SLC22A6—Transmembrane transport of small molecules—ABCB1—esophageal cancer	3.95e-05	0.000946	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—GSTO1—esophageal cancer	3.87e-05	0.000927	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—TPI1—esophageal cancer	3.87e-05	0.000927	CbGpPWpGaD
Enalapril—SLC22A7—Transmembrane transport of small molecules—CREBBP—esophageal cancer	3.77e-05	0.000901	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—ALDOB—esophageal cancer	3.71e-05	0.000888	CbGpPWpGaD
Enalapril—CYP3A4—Biological oxidations—CYP1B1—esophageal cancer	3.69e-05	0.000883	CbGpPWpGaD
Enalapril—CYP3A4—Metapathway biotransformation—CYP1B1—esophageal cancer	3.64e-05	0.000871	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—GAPDH—esophageal cancer	3.57e-05	0.000855	CbGpPWpGaD
Enalapril—SLC15A1—Transmembrane transport of small molecules—CREBBP—esophageal cancer	3.56e-05	0.000852	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—CRABP1—esophageal cancer	3.54e-05	0.000847	CbGpPWpGaD
Enalapril—CYP3A4—Biological oxidations—CYP19A1—esophageal cancer	3.47e-05	0.00083	CbGpPWpGaD
Enalapril—CYP3A4—Metapathway biotransformation—CYP19A1—esophageal cancer	3.42e-05	0.000819	CbGpPWpGaD
Enalapril—ABCB1—Transmembrane transport of small molecules—ABCC2—esophageal cancer	3.39e-05	0.000812	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—GNG7—esophageal cancer	3.37e-05	0.000806	CbGpPWpGaD
Enalapril—SLC22A8—Transmembrane transport of small molecules—CREBBP—esophageal cancer	3.16e-05	0.000758	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—ALDH2—esophageal cancer	3.16e-05	0.000755	CbGpPWpGaD
Enalapril—ABCB1—Transmembrane transport of small molecules—GNG7—esophageal cancer	3.08e-05	0.000737	CbGpPWpGaD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—esophageal cancer	3.04e-05	0.000729	CbGpPWpGaD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—CREBBP—esophageal cancer	3.03e-05	0.000725	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—SLC52A3—esophageal cancer	3.02e-05	0.000724	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—BLVRB—esophageal cancer	3.02e-05	0.000724	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—GSTT1—esophageal cancer	3e-05	0.000718	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—CYP2A6—esophageal cancer	2.97e-05	0.00071	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	2.96e-05	0.000707	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—ENO1—esophageal cancer	2.81e-05	0.000673	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—PTGS1—esophageal cancer	2.81e-05	0.000673	CbGpPWpGaD
Enalapril—SLCO1A2—Transmembrane transport of small molecules—CREBBP—esophageal cancer	2.81e-05	0.000673	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—PSME1—esophageal cancer	2.77e-05	0.000663	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—PSME2—esophageal cancer	2.77e-05	0.000663	CbGpPWpGaD
Enalapril—SLC22A6—Transmembrane transport of small molecules—CREBBP—esophageal cancer	2.64e-05	0.000632	CbGpPWpGaD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—esophageal cancer	2.61e-05	0.000625	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—CA1—esophageal cancer	2.57e-05	0.000616	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—SLC10A2—esophageal cancer	2.57e-05	0.000616	CbGpPWpGaD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—esophageal cancer	2.54e-05	0.000607	CbGpPWpGaD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—esophageal cancer	2.48e-05	0.000594	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	2.42e-05	0.000579	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—CYP1B1—esophageal cancer	2.39e-05	0.000572	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—CA2—esophageal cancer	2.35e-05	0.000563	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—CYP19A1—esophageal cancer	2.25e-05	0.000538	CbGpPWpGaD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—esophageal cancer	2.24e-05	0.000537	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—PLCE1—esophageal cancer	2.19e-05	0.000523	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—ADH7—esophageal cancer	2.19e-05	0.000523	CbGpPWpGaD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—esophageal cancer	2.17e-05	0.000519	CbGpPWpGaD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—esophageal cancer	2.06e-05	0.000494	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—HMOX1—esophageal cancer	2.05e-05	0.000491	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	2.01e-05	0.000482	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—ABCB1—esophageal cancer	1.97e-05	0.000471	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—ADH1B—esophageal cancer	1.92e-05	0.000459	CbGpPWpGaD
Enalapril—ABCB1—Transmembrane transport of small molecules—HMOX1—esophageal cancer	1.88e-05	0.000449	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—BLVRB—esophageal cancer	1.86e-05	0.000446	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—SLC52A3—esophageal cancer	1.86e-05	0.000446	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—TYMP—esophageal cancer	1.83e-05	0.000439	CbGpPWpGaD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—esophageal cancer	1.8e-05	0.00043	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—CYP26A1—esophageal cancer	1.78e-05	0.000427	CbGpPWpGaD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—esophageal cancer	1.76e-05	0.000421	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—ALOX15—esophageal cancer	1.74e-05	0.000416	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—GSTO1—esophageal cancer	1.66e-05	0.000397	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—TPI1—esophageal cancer	1.66e-05	0.000397	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—ALDOB—esophageal cancer	1.59e-05	0.00038	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—SLC10A2—esophageal cancer	1.58e-05	0.000379	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—CA1—esophageal cancer	1.58e-05	0.000379	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—GAPDH—esophageal cancer	1.53e-05	0.000366	CbGpPWpGaD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—esophageal cancer	1.53e-05	0.000365	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—CRABP1—esophageal cancer	1.52e-05	0.000363	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	1.49e-05	0.000356	CbGpPWpGaD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—esophageal cancer	1.48e-05	0.000353	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—CA2—esophageal cancer	1.45e-05	0.000347	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—GNG7—esophageal cancer	1.44e-05	0.000345	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—ALDH2—esophageal cancer	1.35e-05	0.000323	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—PLCE1—esophageal cancer	1.35e-05	0.000322	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—ADH7—esophageal cancer	1.35e-05	0.000322	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—CREBBP—esophageal cancer	1.32e-05	0.000315	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—GSTT1—esophageal cancer	1.28e-05	0.000308	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—CYP2A6—esophageal cancer	1.27e-05	0.000304	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—ENO1—esophageal cancer	1.2e-05	0.000288	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—PTGS1—esophageal cancer	1.2e-05	0.000288	CbGpPWpGaD
Enalapril—ABCB1—Transmembrane transport of small molecules—CREBBP—esophageal cancer	1.2e-05	0.000288	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—PSME2—esophageal cancer	1.19e-05	0.000284	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—PSME1—esophageal cancer	1.19e-05	0.000284	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—ADH1B—esophageal cancer	1.18e-05	0.000283	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—NOS3—esophageal cancer	1.18e-05	0.000282	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—TYMP—esophageal cancer	1.13e-05	0.00027	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—CYP26A1—esophageal cancer	1.1e-05	0.000263	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—PTGS2—esophageal cancer	1.08e-05	0.000258	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—ALOX15—esophageal cancer	1.07e-05	0.000256	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—CYP1B1—esophageal cancer	1.02e-05	0.000245	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—GSTO1—esophageal cancer	1.02e-05	0.000244	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—TPI1—esophageal cancer	1.02e-05	0.000244	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—ALDOB—esophageal cancer	9.79e-06	0.000234	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—CYP19A1—esophageal cancer	9.63e-06	0.00023	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—GAPDH—esophageal cancer	9.42e-06	0.000226	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—CRABP1—esophageal cancer	9.34e-06	0.000224	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—EP300—esophageal cancer	8.96e-06	0.000215	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—GNG7—esophageal cancer	8.88e-06	0.000213	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—HMOX1—esophageal cancer	8.78e-06	0.00021	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—ALDH2—esophageal cancer	8.32e-06	0.000199	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—GSTT1—esophageal cancer	7.92e-06	0.000189	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—CYP2A6—esophageal cancer	7.82e-06	0.000187	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—PTGS1—esophageal cancer	7.42e-06	0.000178	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—ENO1—esophageal cancer	7.42e-06	0.000178	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—PSME2—esophageal cancer	7.31e-06	0.000175	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—PSME1—esophageal cancer	7.31e-06	0.000175	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—PIK3CA—esophageal cancer	6.63e-06	0.000159	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—CYP1B1—esophageal cancer	6.31e-06	0.000151	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—CYP19A1—esophageal cancer	5.93e-06	0.000142	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—CREBBP—esophageal cancer	5.63e-06	0.000135	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—HMOX1—esophageal cancer	5.41e-06	0.00013	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—ABCB1—esophageal cancer	5.19e-06	0.000124	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—NOS3—esophageal cancer	5.04e-06	0.000121	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—PTGS2—esophageal cancer	4.61e-06	0.00011	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—EP300—esophageal cancer	3.84e-06	9.19e-05	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—CREBBP—esophageal cancer	3.47e-06	8.31e-05	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—NOS3—esophageal cancer	3.11e-06	7.44e-05	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—PTGS2—esophageal cancer	2.84e-06	6.8e-05	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—PIK3CA—esophageal cancer	2.84e-06	6.79e-05	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—EP300—esophageal cancer	2.36e-06	5.66e-05	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—PIK3CA—esophageal cancer	1.75e-06	4.19e-05	CbGpPWpGaD
